MILLER, Lawrence G.,WOHL, Barry,LUNSMANN, Walter J.
申请号：
AU2019214891
公开号：
AU2019214891A1
申请日:
2019.01.30
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
In general, the invention relates to pharmaceutical compositions comprising (R)- oxybutynin and a norepinephrine reuptake inhibitor (NRI) and methods of treating Sleep Apnea comprising administering (R)-oxybutynin and a norepinephrine reuptake inhibitor (NRI). In some embodiments, the NRI is atomoxetine.
